Alexanders Inc (ALX) stock
ALXNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3062% below fair value
$245.51−1.88 (-0.76%)
Close on Nov 13, 2026Market cap $1.25BP/E 6.6Yield 7.33%
Alexanders EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Alexanders's EPS for the twelve months ending Sep 30, 2026 was $37.22, up 421.3% year over year. For fiscal 2025 it was $5.50, down 35.0% from the year before. Over ten years it grew -9.6% a year on average. The highest annual figure on record is $132.04 in fiscal 2012.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.50 | -35.0% |
| FY2024 | Dec 31, 2024 | $8.46 | -57.6% |
| FY2023 | Dec 31, 2023 | $19.97 | +77.7% |
| FY2022 | Dec 31, 2022 | $11.24 | -56.7% |
| FY2021 | Dec 31, 2021 | $25.94 | +216.7% |
| FY2020 | Dec 31, 2020 | $8.19 | -30.2% |
| FY2019 | Dec 31, 2019 | $11.74 | +82.9% |
| FY2018 | Dec 31, 2018 | $6.42 | -59.2% |
| FY2017 | Dec 31, 2017 | $15.74 | -6.9% |
| FY2016 | Dec 31, 2016 | $16.91 | +12.4% |
| FY2015 | Dec 31, 2015 | $15.04 | +13.2% |
| FY2014 | Dec 31, 2014 | $13.29 | +19.3% |
| FY2013 | Dec 31, 2013 | $11.14 | -91.6% |
| FY2012 | Dec 31, 2012 | $132.04 | +749.1% |
| FY2011 | Dec 31, 2011 | $15.55 | +19.5% |
| FY2010 | Dec 31, 2010 | $13.01 | -49.7% |
| FY2009 | Dec 31, 2009 | $25.89 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.33 | +359.5% |
| Q2 FY2026 | Jun 30, 2026 | $30.24 | +2441.2% |
| Q1 FY2026 | Mar 31, 2026 | $0.91 | -62.1% |
| Q4 FY2025 | Dec 31, 2025 | $0.74 | -69.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.16 | -10.8% |
| Q2 FY2025 | Jun 30, 2025 | $1.19 | -27.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.40 | -23.6% |
| Q4 FY2024 | Dec 31, 2024 | $2.39 | -24.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.30 | -38.1% |
| Q2 FY2024 | Jun 30, 2024 | $1.63 | -87.0% |
| Q1 FY2024 | Mar 31, 2024 | $3.14 | +43.4% |
| Q4 FY2023 | Dec 31, 2023 | $3.17 | +23.3% |
| Q3 FY2023 | Sep 30, 2023 | $2.10 | -28.8% |
| Q2 FY2023 | Jun 30, 2023 | $12.51 | +332.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.19 | -22.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.57 | -83.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.95 | +32.9% |
| Q2 FY2022 | Jun 30, 2022 | $2.89 | -42.8% |
| Q1 FY2022 | Mar 31, 2022 | $2.84 | -18.6% |
| Q4 FY2021 | Dec 31, 2021 | $15.17 | +321.4% |
| Q3 FY2021 | Sep 30, 2021 | $2.22 | +72.1% |
| Q2 FY2021 | Jun 30, 2021 | $5.05 | +109.5% |
| Q1 FY2021 | Mar 31, 2021 | $3.49 | +292.1% |
| Q4 FY2020 | Dec 31, 2020 | $3.60 | +27.7% |
| Q3 FY2020 | Sep 30, 2020 | $1.29 | -59.9% |
| Q2 FY2020 | Jun 30, 2020 | $2.41 | +9.5% |
| Q1 FY2020 | Mar 31, 2020 | $0.89 | -74.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.82 | +44.6% |
| Q3 FY2019 | Sep 30, 2019 | $3.22 | +9.9% |
| Q2 FY2019 | Jun 30, 2019 | $2.20 | -35.9% |
| Q1 FY2019 | Mar 31, 2019 | $3.49 | – |
| Q4 FY2018 | Dec 31, 2018 | $1.95 | -44.3% |
| Q3 FY2018 | Sep 30, 2018 | $2.93 | -26.2% |
| Q2 FY2018 | Jun 30, 2018 | $3.43 | -15.1% |
| Q1 FY2018 | Mar 31, 2018 | -$1.90 | -144.8% |
| Q4 FY2017 | Dec 31, 2017 | $3.50 | -17.3% |
| Q3 FY2017 | Sep 30, 2017 | $3.97 | – |
| Q2 FY2017 | Jun 30, 2017 | $4.04 | – |
| Q1 FY2017 | Mar 31, 2017 | $4.24 | – |
| Q4 FY2016 | Dec 31, 2016 | $4.23 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?